Baolingbao Biology Co Ltd - Asset Resilience Ratio

Latest as of December 2023: -0.77%

Baolingbao Biology Co Ltd (002286) has an Asset Resilience Ratio of -0.77% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥-20.42 Million

≈ $-2.99 Million USD Cash + Short-term Investments

Total Assets

CN¥2.66 Billion

≈ $389.08 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2023)

This chart shows how Baolingbao Biology Co Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Baolingbao Biology Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Baolingbao Biology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002286 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-20.42 Million	-0.77%
Total Liquid Assets	CN¥-20.42 Million	-0.77%

Asset Resilience Insights

Limited Liquidity: Baolingbao Biology Co Ltd maintains only -0.77% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Baolingbao Biology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Baolingbao Biology Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
Pharvaris BV NASDAQ:PHVS	Biotechnology	0.06%
Pacific Shuanglin Bio pharmacy Co Ltd SHE:000403	Biotechnology	2.81%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Shanghai Haohai Biological Tech Co SHG:688366	Biotechnology	1.51%

Annual Asset Resilience Ratio for Baolingbao Biology Co Ltd (2013–2023)

The table below shows the annual Asset Resilience Ratio data for Baolingbao Biology Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-0.77%	CN¥-20.42 Million ≈ $-2.99 Million	CN¥2.66 Billion ≈ $389.08 Million	-4.29pp
2021-12-31	3.52%	CN¥106.67 Million ≈ $15.61 Million	CN¥3.03 Billion ≈ $443.24 Million	+3.73pp
2020-12-31	-0.21%	CN¥-5.48 Million ≈ $-802.34K	CN¥2.62 Billion ≈ $382.76 Million	+0.09pp
2019-12-31	-0.30%	CN¥-7.62 Million ≈ $-1.12 Million	CN¥2.52 Billion ≈ $368.57 Million	+0.10pp
2018-12-31	-0.41%	CN¥-10.51 Million ≈ $-1.54 Million	CN¥2.58 Billion ≈ $377.43 Million	-0.29pp
2017-12-31	-0.12%	CN¥-2.44 Million ≈ $-357.60K	CN¥2.11 Billion ≈ $308.31 Million	0.00pp
2016-12-31	-0.11%	CN¥-2.15 Million ≈ $-314.40K	CN¥1.93 Billion ≈ $282.65 Million	-0.02pp
2015-12-31	-0.09%	CN¥-1.81 Million ≈ $-265.48K	CN¥1.91 Billion ≈ $280.01 Million	+0.01pp
2014-12-31	-0.11%	CN¥-1.91 Million ≈ $-279.19K	CN¥1.77 Billion ≈ $258.44 Million	+0.01pp
2013-12-31	-0.12%	CN¥-2.00 Million ≈ $-292.89K	CN¥1.68 Billion ≈ $245.28 Million	--

pp = percentage points

About Baolingbao Biology Co Ltd

SHE:002286 China Biotechnology

Market Cap

$445.51 Million

CN¥3.04 Billion CNY

Market Cap Rank

#12864 Global

#3780 in China

Share Price

CN¥8.00

Change (1 day)

-0.87%

52-Week Range

CN¥7.21 - CN¥11.75

All Time High

CN¥23.40